Back
Theravance Biopharma, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
62
TBPH
Theravance Biopharma, Inc.
Last Price:
$20.11
Seasonality Move:
0.02%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
Theravance Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.28 | Buy |
| 20-day SMA: | 18.8 | Buy |
| 50-day SMA: | 18.14 | Buy |
| 200-day SMA: | 13.27 | Buy |
| 8-day EMA: | 19.56 | Buy |
| 20-day EMA: | 18.97 | Buy |
| 50-day EMA: | 17.94 | Buy |
| 200-day EMA: | 14.3 | Buy |
Theravance Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 71.4 | Buy |
| Chaikin Money Flow: | 232485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.85 - 19.37) | Buy |
| Bollinger Bands (100): | (13.87 - 18.37) | Buy |
Theravance Biopharma, Inc. Technical Analysis
| Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 31 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma, Inc. Stock
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 20.61 while TBPH 8-day simple moving average is 19.28, which is a Buy signal.
-
The stock price of TBPH is 20.61 while Theravance Biopharma, Inc. 20-day SMA is 18.80, which makes it a Buy.
-
Theravance Biopharma, Inc. 50-day simple moving average is 18.14 while TBPH share price is 20.61, making it a Buy technically.
-
TBPH stock price is 20.61 and Theravance Biopharma, Inc. 200-day simple moving average is 13.27, creating a Buy signal.
TBPH Technical Analysis vs Fundamental Analysis
Buy
62
Theravance Biopharma, Inc. (TBPH)
is a Buy
Is Theravance Biopharma, Inc. a Buy or a Sell?
-
Theravance Biopharma, Inc. stock is rated a BuyThe current Theravance Biopharma, Inc. [TBPH] share price is $20.61. The Score for TBPH is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Theravance Biopharma, Inc. Stock Info
Market Cap:
1B
Price in USD:
20.61
Share Volume:
306.9K
Theravance Biopharma, Inc. 52-Week Range
52-Week High:
20.69
52-Week Low:
7.90
Buy
62
Theravance Biopharma, Inc. (TBPH)
is a Buy
Theravance Biopharma, Inc. Share Price Forecast
-
What is the Theravance Biopharma, Inc. stock price today?The Theravance Biopharma, Inc. stock price is 20.61 USD today.
-
Will TBPH stock go up or go down?Theravance Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Theravance Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma, Inc. is not overvalued.
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 20.61 while TBPH 8-day exponential moving average is 19.56, which is a Buy signal.
-
The stock price of TBPH is 20.61 while Theravance Biopharma, Inc. 20-day EMA is 18.97, which makes it a Buy.
-
Theravance Biopharma, Inc. 50-day exponential moving average is 17.94 while TBPH share price is 20.61, making it a Buy technically.
-
TBPH stock price is 20.61 and Theravance Biopharma, Inc. 200-day simple moving average is 14.30, creating a Buy signal.
Fundamental Analysis of Theravance Biopharma, Inc.
Is Theravance Biopharma, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.26 per share.
Technical Analysis of Theravance Biopharma, Inc.
Should I short Theravance Biopharma, Inc. stock?
-
TBPH Moving Average Covergence Divergence (MACD) indicator is 0.53, suggesting Theravance Biopharma, Inc. is a Buy
-
Theravance Biopharma, Inc. Relative Strength Index (RSI) is 71.4, which suggest Theravance Biopharma, Inc. is overbought
-
The Bollinger Bands (25) for Theravance Biopharma, Inc. is (17.85 - 19.37), which suggest Theravance Biopharma, Inc. is a Buy
-
The Bollinger Bands (100) for Theravance Biopharma, Inc. is (13.87 - 18.37), which suggest Theravance Biopharma, Inc. is a Buy
* Theravance Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.